Mitral valve apparatus in Hypertrophic Cardiomyopathy: a specific assessment?
|
|
- Dorcas King
- 5 years ago
- Views:
Transcription
1 Nancy, September 17th, 2015 Mitral valve apparatus in Hypertrophic Cardiomyopathy: a specific assessment? Inserm UMR1087 Institut du Thorax, Nantes Thierry le Tourneau
2 Déclaration de Relations Professionnelles - Disclosure Statement of Financial Interest J'ai actuellement, ou j'ai eu au cours des quatre dernières années, une affiliation ou des intérêts financiers ou intérêts de tout ordre avec une société commerciale ou je reçois une rémunération ou des redevances ou des octrois de recherche d'une société commerciale : I currently have, or have had over the last five years, an affiliation or financial interests or interests of any order with a company or I receive compensation or fees or research grants with a commercial company : Affiliation/Financial Relationship Company Consulting Fees/Honoraria Congress Invitation-Meeting lunch GE healthcare, Philips BMS Daiichi-Sankyo Edwards Daiichi-Sankyo Servier Edwards, Abbott
3 Mitral Valve Apparatus in HCM - Echocardiography (leaflets +++) - Cardiac Magnetic Resonance Imaging (PM +++) - 3D Echo - Exercise Echocardiography +++
4 Pathophysiology: Mitral remodeling - Anomalies of Mitral valve apparatus Congenital: development alteration Acquired: remodeling of mitral valve apparatus associated with myocardial remodeling - Alterations : Mitral leaflets Chords Papillary muscles
5 Mitral Valve Anomalies of HCM
6 Mitral Valve: Lengthening Anterior Leaflet Length: 26 5 mm vs 19 5 mm Posterior Leaflet Length: 14 4 vs 10 3 mm Primary phenotypic trait Involved in LVOT obstruction 42mm Kim DH, Circulation 2010; 122: Maron MS, Circulation 2011; 124: 40-47
7 Mitral Valve: Lengthening Kim DH, Circulation 2010; 122: Maron MS, Circulation 2011; 124: 40-47
8 Mitral Valve: Lengthening Kim DH, Circulation 2010; 122: Maron MS, Circulation 2011; 124: 40-47
9 Chords: abnormal chordal insertion Patel P, Circ CV Img 2015; 8: epub
10 Papillary Muscles: Hypertrophy - Hypertrophy (CMR Img: 6±2 vs 3±2 g/m²) associated with increased (88%) or normal LV mass and localized wall thickness (12%) Harrigan CJ, Am J Cardiol 2008; 101:
11 Papillary Muscles: Hypertrophy Kwon DH, Heart 2008; 94:
12 Papillary Muscles: Hypertrophy Harrigan CJ, Am J Cardiol 2008; 101:
13 Papillary Muscles: Number - Multiples PM: 2.5 in 200 HCM vs 2.1 in 43 controls (P<0.001) - Accessory PMs (6%) Harrigan CJ, Am J Cardiol 2008; 101:
14 Papillary Muscles: Bifid - Double bifid PM (70% vs 17% in controls) Double bifid Kwon DH, Heart 2008; 94:
15 Papillary Muscles: Antero position - Antero-apical displacement of anterolateral PM (77% vs 17%, P<0.001) Normal PMs Abnormal PMs Kwon DH, Heart 2008; 94:
16 Papillary Muscles Anterior displacement Odds ratio of significant obstruction: -Double bifid: OR Anterior displaced: 0R 7.1 Kwon DH, Heart 2008; 94:
17 Papillary Muscles: Mobility Predictors of LVOT gradient: -Basal septal thickness -Bifid PM mobility -AML length -Abnormal chordal attachement to the base of AML Patel P, Circ CV Img 2015; 8: epub
18 Degenerative Mitral Valve Prolapse
19 Mitral Valve Prolapse - 3% des patients avec CMH, association fortuite - Isolated postero-latero basal LV free wall hypertrophy and Mitral valve prolapse Petrone RK, JACC 1992; 20: Maron BJ, AJC 2010; 106: 750-2
20 Flail Leaflet: Chord rupture - Chordal rupture without known MVP - Likely favoured by obstruction - Mayo Clinic: 32 cases operated : 4% myomectomy, 3% mitral valve repair Wan CK, Ann Thorac Surg, 2009, 88: Zia MI, Am J Cardiol, 2012, 109:
21 Flail Leaflet: Chord rupture Boissier F, ACVD 2015; 108: HCM patients -6 (1%) chordal rupture -5 men, 1 women, 70±5 yrs -Delay from HCM to diagnosis: 16±3 yrs -No MVP before CRupture -Obstruction in all patients before rupture: 56±17 mmhg -Regression of obstruction after chordal rupture
22 Conclusion: Mitral Valve in HCM Assessment by echocardiography and CMR Imaging Mitral leaflet: length and dynamics Chordal alteration: attachment, tension Papillary muscles: number, position, mobility Obstruction (rest or latent)
23 Anterior displacement of MV apparatus
24 Mitral valve: SAM
25 Mitral valve: SAM Mechanism of obstruction Anomalies of mitral valve apparatus -antero-displacement of the mitral valve apparatus, mitral coaptation point -Pushing of the anterior leaflet by the posterior one -Pushing of leaflets by ejection flow deviated by septal hypertrophy Venturi effect Septal hypertrophy and hyperkinesy Flow acceleration, hydrostatic depression, and attraction of the mitral leaflet toward the septum
26 Pathophysiology: LV remodeling Wall hypertrophy Myocardial fibrosis LVOT obstruction Genetic factors Environments factors Wall stress C LV remodeling activation Fœtal program reexpression Hypertrophy, Apoptosis, Fibrosis
Insuffisance mitrale
Imagerie Multimodalité dans les Valvulopathies: De quoi avons nous besoin? Insuffisance mitrale Agnès Pasquet, MD, PhD Pôle de Recherche Cardiovasculaire Institut de Recherche Expérimentale et Clinique
More informationHypertrophic Cardiomyopathy or «Athlete s Heart»
Hypertrophic Cardiomyopathy or «Athlete s Heart» S. GUERARD, J-R. CAIGNAULT, V. GRIFFET Desgenettes Military Hospital LYON Déclaration de Relations Professionnelles Disclosure Statement of Financial Interest
More informationWhat is controversial in diagnostic imaging?
Controversies in the management of pulmonary hypertension What is controversial in diagnostic imaging? G. Derumeaux Lyon University Hospices Civils de Lyon France Déclaration de Relations Professionnelles
More informationMYOCARDITIS AND BIOMARKERS. Dr C. Guenancia Service de Cardiologie CHU Dijon
MYOCARDITIS AND BIOMARKERS Dr C. Guenancia Service de Cardiologie CHU Dijon Déclaration de Relations Professionnelles Disclosure Statement of Financial Interest J'ʹai actuellement, ou j'ʹai eu au cours
More informationEchocardiography of the young athlete: Where are the limits? 24 èmes Journées Européennes de la Société Française de cardiologie janvier 2014
Echocardiography of the young athlete: Where are the limits? 24 èmes Journées Européennes de la Société Française de cardiologie 15-18 janvier 2014 Sylvain GUERARD LYON-BRON Déclaration de Relations Professionnelles
More informationP. Messner Pellenc, C. Robert
P. Messner Pellenc, C. Robert Déclaration de Relations Professionnelles Disclosure Statement of Financial Interest J'ai actuellement, ou j'ai eu au cours des deux dernières années, une affiliation ou des
More informationL essentiel de 2013 Exercice Readaptation et Sport (GERS) Dr Marie Christine Iliou
PARIS 15-19 Janvier 2014 L essentiel de 2013 Exercice Readaptation et Sport (GERS) Dr Marie Christine Iliou Déclaration de Relations Professionnelles Disclosure Statement of Financial Interest J'ai actuellement,
More informationParadoxical low flow-low gradient severe aortic stenosis: where are we?
Journées Européennes de la SFC Paris, 15 janvier 2016 Paradoxical low flow-low gradient severe aortic stenosis: where are we? Nicolas Mansencal Hôpital Ambroise Paré, Boulogne Centre de Réf ce pour les
More informationRest and Exercise Echocardiography in Hypertrophic Cardiomyopathy: Determinants of Exercise Peak Gradient and Predictors of Outcome
Rest and Exercise Echocardiography in Hypertrophic Cardiomyopathy: Determinants of Exercise Peak Gradient and Predictors of Outcome G. Deswarte, AS. Polge, N. Lamblin, A. Millaire, M. Richardson, C. Bauters,
More informationContinuous and noninvasive arterial blood pressure monitoring
Continuous and noninvasive arterial blood pressure monitoring Pr. Jean-Luc Fellahi fellahi-jl@chu-caen.fr Pôle Réanimations-Anesthésie-SAMU, CHU de Caen UFR de Médecine, EA4650, Université de Caen Basse-Normandie
More informationSurgical Myectomy for HOCM
Surgical Myectomy for HOCM Volkmar Falk Deutsches Herzzentrum Berlin Different Pathology of HOCM Impact on surgical strategy Said SM Expert Rev Cardiovasc Ther 2013 Different Pathology of HOCM Impact on
More informationReturn to Work (RTW) after Acute Coronary Syndrom (ACS) SFC
+ Return to Work (RTW) after Acute Coronary Syndrom (ACS) SFC - 2016 No Conflict of interest for this subject Dany Michel Marcadet Paris Déclaration de Relations Professionnelles Disclosure Statement of
More informationUtility of Echocardiography
Hypertrophic Cardiomyopathy and Beyond- Echo Hawaii 2018 Lawrence Rudski MD FRCPC FACC FASE Professor of Medicine Director, Division of Cardiology and Azrieli Heart Center Jewish General Hospital, McGill
More informationHow NOT to miss Hypertrophic Cardiomyopathy? Adaya Weissler-Snir, MD University Health Network, University of Toronto
How NOT to miss Hypertrophic Cardiomyopathy? Adaya Weissler-Snir, MD University Health Network, University of Toronto Introduction Hypertrophic cardiomyopathy is the most common genetic cardiomyopathy,
More informationHOCM: Alcohol ablation or LVOT Surgery: When and what?
HOCM: Alcohol ablation or LVOT Surgery: When and what? Paul R Vogt/ Pascal A. Berdat Cardiovascular Center Zurich Clinic Im Park Zurich SKG/SGHC Annual Meeting, Zurich, 10.-12.6.15 ASA/Myectomy: Common
More informationCardiac Rehabilitation and Electromyostimulation
CREMS-HF Cardiac Rehabilitation and Electromyostimulation Dr Marie Christine Iliou Dr Bénédicte Vergès CREMS-HF study GERS SFC Déclaration de Relations Professionnelles Disclosure Statement of Financial
More informationCancer Associated Thrombosis Approach to VTE recurrence
Cancer Associated Thrombosis Approach to VTE recurrence http://anticoag-pass-s2d.fr/ Isabelle Mahé Hôpital Louis Mourier Service de Médecine Interne APHP-Université Paris 7 EA REMES 7334-UMR 1140 France
More informationGenotype Positive/ Phenotype Negative: Is It a Disease?
Genotype Positive/ Phenotype Negative: Is It a Disease? Michelle Michels MD, PhD Center of Inherited Cardiovascular Diseases Erasmus MC, Rotterdam, the Netherlands No disclosures What is phenotype negative
More informationLeft Ventricular Assist Device and Exercise
Left Ventricular Assist Device and Exercise Marie Christine Iliou Réadaptation cardiaque et prévention secondaire Hôpital Corentin Celton- HUPO Issy les Moulineaux Déclaration de Relations Professionnelles
More information«Which stent for which coarctation based on mechanical properties?» Modelisation
«Which stent for which coarctation based on mechanical properties?» Modelisation Patrice Guérin, Clément Mercier, Fabienne Jordanna L Institut du Thorax et Inserm U791 CHU Nantes JFCPC 2015 Déclaration
More informationRoutine MitraClip. Image Guidance Step by Step
Routine MitraClip Image Guidance Step by Step Douglas C. Shook, MD, FASE Director, Cardiothoracic Anesthesia Fellowship Director, Cardiac Interventional Anesthesia Department of Anesthesiology BRIGHAM
More informationHYPERTROPHIC CARDIOMYOPATHY: Severe Heart Failure. Paolo Spirito, Genoa, Italy
HYPERTROPHIC CARDIOMYOPATHY: Severe Heart Failure Paolo Spirito, Genoa, Italy Clinical Substrates for Heart Failure Symptoms in HCM Diastolic dysfunction Atrial fibrillation LV outflow obstruction Evolution
More informationProfessor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017
James S. Gammie, MD Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical The Houston Aortic Symposium February 2-25, 2017 Disclosure Statement of Financial Interest Within
More informationValve Analysis and Pathoanatomy: THE MITRAL VALVE
: THE MITRAL VALVE Marc R. Moon, M.D. John M. Shoenberg Chair in CV Disease Chief, Cardiac Surgery Washington University School of Medicine, St. Louis, MO Secretary, American Association for Thoracic Surgery
More informationmarked increase in thickness of walls of heart in patient with HCM.
Surgical Management of Hypertrophic Obstructive Cardiomyopathy Hani K. Najm MD, Msc, FRCSC, FRCS (Glasg Glasg), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi
More information8/31/2016. Mitraclip in Matthew Johnson, MD
Mitraclip in 2016 Matthew Johnson, MD 1 Abnormal Valve Function Valve Stenosis Obstruction to valve flow during that phase of the cardiac cycle when the valve is normally open. Hemodynamic hallmark - pressure
More informationNancy Goldman Cutler, MD Beaumont Children s Hospital Royal Oak, Mi
Nancy Goldman Cutler, MD Beaumont Children s Hospital Royal Oak, Mi Identify increased LV wall thickness (WT) Understand increased WT in athletes Understand hypertrophic cardiomyopathy (HCM) Enhance understanding
More informationManagement of HOCM: Non-Surgical Options
Management of HOCM: Non-Surgical Options Howard C. Herrmann, MD, FACC, MSCAI John Bryfogle Professor of Cardiovascular Medicine and Surgery Health System Director for Interventional Cardiology Director,
More informationThe Management of HOCM: What are the Surgical Options
The Management of HOCM: What are the Surgical Options Konstadinos A Plestis, MD System Chief of Cardiac Thoracic and Vascular Surgery Main Line Health Care System Professor Sidney Kimmel Medical College
More informationCardiac hypertrophy : differentiating disease from athlete
Cardiac hypertrophy : differentiating disease from athlete Ario Soeryo Kuncoro, MD, Cardiologist Echocardiography Division, National Cardiovascular Centre Harapan Kita-Jakarta Departement of Cardiology
More informationHypertrophic Cardiomyopathy: basics and management
Hypertrophic Cardiomyopathy: basics and management Bette Kim, MD Program Director, Cardiomyopathy Program Director, Roosevelt Hospital Echocardiography Lab Assistant Professor of Clinical Medicine Mount
More informationDegenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention
Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention John N. Hamaty D.O. FACC, FACOI November 17 th 2017 I have no financial disclosures Primary Mitral
More informationHypertrophic Cardiomyopathy: Patient Management in 2018
Hypertrophic Cardiomyopathy: Patient Management in 2018 Mackram F. Eleid, MD Giornate Cardiologeche Torinesi October 26, 2018 2018 MFMER slide-1 Disclosures No relevant financial relationships to disclose
More informationMitraClip in the ICCU: Which Patient will Benefit?
MitraClip in the ICCU: Which Patient will Benefit? DAVID MEERKIN STRUCTURAL A ND CONGENITAL HEART DISEASE UNIT SHAARE ZEDEK MEDICAL CENTER JERUSALEM Conflict of Interest No relevant disclosures Complex
More informationHypertrophic Cardiomyopathy: beyond gradient and wall thickness
Hypertrophic Cardiomyopathy: beyond gradient and wall thickness Michael H. Picard, M.D. Massachusetts General Hospital Harvard Medical School no disclosures special thanks to A. Baggish 1 Hypertrophic
More informationPrimary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017
Disclosures: GE stock, Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Athena Poppas, MD FACC Past ACC Scientific Sessions Chair, ACC Board
More informationOutline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II
SURGICAL RISK IN VALVULAR HEART DISEASE: WHAT 2D AND 3D ECHO CAN TELL YOU AND WHAT THEY CAN'T Ernesto E Salcedo, MD Professor of Medicine University of Colorado School of Medicine Director of Echocardiography
More informationAssessing the Impact on the Right Ventricle
Advances in Tricuspid Regurgitation Congress of the European Society of Cardiology (ESC) Munich, August 25-29, 2012 Assessing the Impact on the Right Ventricle Stephan Rosenkranz, MD Clinic III for Internal
More informationManaging Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology
Managing Hypertrophic Cardiomyopathy with Imaging Gisela C. Mueller University of Michigan Department of Radiology Disclosures Gadolinium contrast material for cardiac MRI Acronyms Afib CAD Atrial fibrillation
More informationCardiac MRI: Cardiomyopathy
Cardiac MRI: Cardiomyopathy Laura E. Heyneman, MD I do not have any relevant financial relationships with any commercial interests Cardiac MRI: Cardiomyopathy Laura E. Heyneman, MD Duke University Medical
More informationWhat s New in Cardiac MRI
What s New in Cardiac MRI Katie M. Hawthorne, MD Director, Cardiac MRI Main Line Health Philadelphia Cardiovascular Summit November 18, 2017 Cardiac MRI: Disclosure 2 Disclosures No financial disclosures
More informationRestrictive Cardiomyopathy
ESC Congress 2011, Paris Imaging Unusual Causes of Cardiomyopathy Restrictive Cardiomyopathy Kazuaki Tanabe, MD, PhD Professor of Medicine Chair, Division of Cardiology Izumo, Japan I Have No Disclosures
More informationGlobal left ventricular circumferential strain is a marker for both systolic and diastolic myocardial function
Global left ventricular circumferential strain is a marker for both systolic and diastolic myocardial function Toshinari Onishi 1, Samir K. Saha 2, Daniel Ludwig 1, Erik B. Schelbert 1, David Schwartzman
More informationDisclosure Statement of Financial Interest Saibal Kar, MD, FACC
MitraClip Therapy Saibal Kar, MD, FACC, FAHA, FSCAI Director of Interventional Cardiac Research Program Director, Interventional Cardiology Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA
More informationWhat is Ebstein Anomaly?
Echocardiograpnhic Evaluation of : Definition, Detection and Determinants of Outcome P. W. O Leary, M.D. Division of Pediatric Cardiology Mayo Clinic No Conflicts to Disclose What is? Failure of the TV
More information(Ann Thorac Surg 2008;85:845 53)
I Made Adi Parmana The utility of intraoperative TEE has become increasingly more evident as anesthesiologists, cardiologists, and surgeons continue to appreciate its potential application as an invaluable
More informationAlcohol Septal Abla-on: Is This Now First Line Treatment for Hypertrophic Obstruc-ve Cardiomyopathy (HOCM)?
Alcohol Septal Abla-on: Is This Now First Line Treatment for Hypertrophic Obstruc-ve Cardiomyopathy (HOCM)? Sarang Mangalmur+, MD Bryn Mawr Hospital, PA NCVH New Jersey 2015 Disclosures No relevant disclosures
More informationTHE FOLDING LEAFLET. Rafael García Fuster. Cardiac Surgery Department University General Hospital of Valencia
THE FOLDING LEAFLET Rafael García Fuster Cardiac Surgery Department University General Hospital of Valencia School of Medicine Catholic University of Valencia San Vicente Mártir SPAIN Carpentier s principles
More informationORIGINAL PAPER. R. C. Steggerda & J. C. Balt & K. Damman & M. P. van den Berg & J. M. ten Berg
Neth Heart J (2013) 21:504 509 DOI 10.1007/s12471-013-0453-4 ORIGINAL PAPER Predictors of outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Special interest
More informationMR echo case. N.Koutsogiannis Department of Cardiology University Hospital Of Patras
MR echo case N.Koutsogiannis Department of Cardiology University Hospital Of Patras Case A 35 years old male came to the echo lab for a third opinion for his valvulopathy. He reports a long standing MR
More informationOrganic mitral regurgitation
The best in heart valve disease Organic mitral regurgitation Ewa Szymczyk Department of Cardiology Medical University of Lodz, Poland I have nothing to declare Organic mitral regurgitation leaflet abnormality
More informationPercutaneous Mitral Valve Repair
Percutaneous Mitral Valve Repair MitraClip: Procedure, Data, Patient Selection Chad Rammohan, MD FACC Director, Cardiac Cath Lab El Camino Hospital Mountain View, California Mitral Regurgitation MitraClip
More informationEchocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016
Echocardiographic Evaluation of the Cardiomyopathies Stephanie Coulter, MD, FACC, FASE April, 2016 Cardiomyopathies (CMP) primary disease intrinsic to cardiac muscle Dilated CMP Hypertrophic CMP Infiltrative
More informationHYPERTROPHY: Behind the curtain. V. Yotova St. Radboud Medical University Center, Nijmegen
HYPERTROPHY: Behind the curtain V. Yotova St. Radboud Medical University Center, Nijmegen Disclosure of interest: none Relative wall thickness (cm) M 0.22 0.42 0.43 0.47 0.48 0.52 0.53 F 0.24 0.42 0.43
More informationΣεμινάρια Ομάδων Εργασίας 2017 Ανεπάρκεια μιτροειδούς μυξωματώδους αιτιολογίας
Σεμινάρια Ομάδων Εργασίας 2017 Ανεπάρκεια μιτροειδούς μυξωματώδους αιτιολογίας Μυτάς Δημήτρης MD, PhD Επιμ Α ΕΣΥ Σισμανόγλειο Γενικό Νοσοκομείο Αττικής Δηλώνω υπεύθυνα ότι η παρούσα ομιλία δεν επιχορηγείται
More informationWhat s new in Hypertrophic Cardiomyopathy?
What s new in Hypertrophic Cardiomyopathy? Dr Andris Ellims HCM Clinic @ The Alfred Hypertrophic Cardiomyopathy = otherwise unexplained LV hypertrophy* 1 in 500 prevalence most common inherited cardiovascular
More informationTricuspid and Pulmonary Valve Disease
Tricuspid and Pulmonary Valve Disease Lawrence Rudski MD FRCPC FACC FASE Professor of Medicine Director, Division of Cardiology Jewish General Hospital McGill University Right Sided Failure Edema Gut congestion
More informationBulging Subaortic Septum: An Important Risk Factor for Systolic Anterior Motion After Mitral Valve Repair
Bulging Subaortic Septum: An Important Risk Factor for Systolic Anterior Motion After Mitral Valve Repair Sameh M. Said, MD, Hartzell V. Schaff, MD, Rakesh M. Suri, MD, DPhil, Kevin L. Greason, MD, Joseph
More informationUpdate on Evaluation and Nonsurgical Treatment Strategies for the Symptomatic Patient with HCM
Update on Evaluation and Nonsurgical Treatment Strategies for the Symptomatic Patient with HCM Richard G. Bach, MD, FACC, FAHA Professor of Medicine Director, Hypertrophic Cardiomyopathy Center Washington
More informationOutcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease
Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve
More informationHypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy Vincent L. Sorrell, MD Anthony N. DeMaria Professor of Medicine (Card/ Rad) University of Kentucky / Gill Heart Institute Assistant Chief, Division of Cardiovascular Medicine
More informationLate secondary TR after left sided heart disease correction: is it predictibale and preventable
Late secondary TR after left sided heart disease correction: is it predictibale and preventable Gilles D. Dreyfus Professor of Cardiothoracic surgery Nath J, et al. JACC 2004 PREDICT Incidence of secondary
More informationTechniques for ischemic mitral valve disease: An Update. Stanford CV Surgery
Techniques for ischemic mitral valve disease: An Update Conflict of Interest Disclosure Grant/ Research Support: NHLBI RO1 HL67025 Consulting Fees/Honoraria: Stanford PI PARTNER Trial, Edwards Lifesciences
More informationHighlights from EuroEcho 2009 Echo in cardiomyopathies
Highlights from EuroEcho 2009 Echo in cardiomyopathies Bogdan A. Popescu University of Medicine and Pharmacy, Bucharest, Romania ESC Congress 2010 Hypertrophic cardiomyopathy To determine the differences
More informationIschemic Mitral Regurgitation
Ischemic Mitral Regurgitation Jean-Louis J. Vanoverschelde, MD, PhD Université catholique de Louvain Brussels, Belgium Definition Ischemic mitral regurgitation is mitral regurgitation due to complications
More informationNON-INVASIVE TREATMENT OPTIONS IN HYPERTROPHIC CARDIOMYOPATHY
NON-INVASIVE TREATMENT OPTIONS IN HYPERTROPHIC CARDIOMYOPATHY SGK, 2015 Christiane Gruner University Heart Center, Zurich Department of Cardiology NONINVASIVE TREATMENT OPTIONS: TOPICS 1. LVOT obstruction
More informationMitral Valve Disease, When to Intervene
Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages
More informationΜαρία Δρακοπούλου, Σοφία Βαïνά
Μαρία Δρακοπούλου, Σοφία Βαïνά Α Πανεπιστημιακή Καρδιολογική Κλινική Ιπποκράτειο Νοσοκομείο Spectrum of mitral regurgitation German Heart Report 2017 MitraClip implantations have numerically outperformed
More informationAtrioventricular valve repair: The limits of operability
Atrioventricular valve repair: The limits of operability Francis Fynn-Thompson, MD Co-Director, Center for Airway Disorders Surgical Director, Pediatric Mechanical Support Program Surgical Director, Heart
More informationΕπιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων. Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος
Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος MV anatomy Otto C. NEJM 2001 Leaflets anatomy 2% of population Etiology Terminology
More informationPercutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat
Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,
More informationAnaesthesia for non-cardiac surgery in patients left ventricular outflow tract obstruction (LVOTO)
Anaesthesia for non-cardiac surgery in patients left ventricular outflow tract obstruction (LVOTO) Dr. Siân Jaggar Consultant Anaesthetist Royal Brompton Hospital London UK Congenital Cardiac Services
More informationOverview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan
Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan Degenerative MR is not Functional MR 2o - Functional MR : Ventricular Problem!!
More information27-year-old professionnal rugby player: asymptomatic
27-year-old professionnal rugby player: asymptomatic Benefits and limits of cardiac MRI in the young athlete with a suspected heart disease. Philippe PAULE Service de Cardiologie, HIA Clermont Tonnerre,
More informationAlcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. CardioVascular Research Foundation
Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Alcohol Septal Ablation (ASA) Nonsurgical technique for septal myocardial reduction Dramatic hemodynamic improvement Technically easy
More informationOutcomes of the Initial Experience with Commercial Transcatheter Mitral Valve Repair in the U.S.
ACC 2015 LBCT Outcomes of the Initial Experience with Commercial Transcatheter Mitral Valve Repair in the U.S. A report from the STS/ACC TVT Registry Paul Sorajja, MD, Saibal Kar, MD, Amanda Stebbins,
More informationSystolic Anterior Motion of Mitral Valve Subchordal Apparatus: A Rare Echocardiographic Pattern in Non- Obstructive Hypertrophic Cardiomyopathy
Case Report Cardiol Res. 2017;8(5):258-264 Systolic Anterior Motion of Mitral Valve Subchordal Apparatus: A Rare Echocardiographic Pattern in Non- Obstructive Hypertrophic Cardiomyopathy Jezreel L. Taquiso
More informationΧειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας
Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Dr Χρήστος ΑΛΕΞΙΟΥ MD, PhD, FRCS(Glasgow), FRCS(CTh), CCST(UK) Consultant Cardiothoracic Surgeon Normal Mitral Valve Function Mitral Regurgitation
More information3D Printing & Echocardiography
ASE SOTA Feb 19, 2018 3D Printing & Echocardiography Stephen H. Little, MD John S. Dunn Chair in Cardiovascular Research and Education, Associate professor, Weill Cornell Medicine Disclosures Personal
More informationSteel vs Alcohol. Or Neither. Management of Hypertrophic Cardiomyopathy. Josh Doll, MD January 24, 2015
Steel vs Alcohol Or Neither Management of Hypertrophic Cardiomyopathy Josh Doll, MD January 24, 2015 47yo Male, Mr. L Severe progressive dyspnea on exertion and weight gain Previous avid Cross-Fit participant
More informationMITRAL STENOSIS. Joanne Cusack
MITRAL STENOSIS Joanne Cusack BSE Breakdown Recognition of rheumatic mitral stenosis Qualitative description of valve and sub-valve calcification and fibrosis Measurement of orifice area by planimetry
More informationPrimary Mitral Regurgitation
EURO VALVE Madrid News from Valves Guidelines 2012: What s new and Why? Primary Mitral Regurgitation Luc A. Pierard, MD, PhD Professor of Medicine Head of the Department of Cardiology Heart Valve Clinic,
More informationLeft ventricular outflow tract obstruction: indications and limitations of current therapies
Left ventricular outflow tract obstruction: indications and limitations of current therapies Costas O Mahony Inherited Cardiovascular Diseases Unit, The Heart Hospital, London, UK. None to declare Conflicts
More informationGiovanni Di Salvo MD, PhD, FESC Second University of Naples Monaldi Hospital
Giovanni Di Salvo MD, PhD, FESC Second University of Naples Monaldi Hospital VSD is one of the most common congenital cardiac abnormalities in the newborn. It can occur as an isolated finding or in combination
More informationThe 2014 Mayo Approach to the Management of HCM and Non-Compaction
The 2014 Mayo Approach to the Management of HCM and Non-Compaction R A Nishimura MD MACC MACP Judd and Mary Morris Leighton Professor Mayo Clinic No disclosures or conflict of interest CP1288794-1 Let
More informationPercutaneous mitral valve repair/replacement. Jan Van der Heyden MD, PhD St.Antonius Hospital Nieuwegein
Percutaneous mitral valve repair/replacement Jan Van der Heyden MD, PhD St.Antonius Hospital Nieuwegein Mitral Valve anatomy Difference between AoV and MV Aortic Valve Mitral Valve Transcatheter Mitral
More informationInterventional Imaging Cases
Interventional Imaging Cases Steven A. Goldstein MD Professor of Medicine Georgetown University Medical Center MedStar Heart Institute Washington Hospital Center Tuesday, October 10, 2017 DISCLOSURE I
More informationImaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015
Imaging MV Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015 MV/MR: information needed on.. 1. MV anatomy 2. MR etiology - primary vs secondary 3. MR severity quantification
More informationCLIP ΜΙΤΡΟΕΙ ΟΥΣ: ΠΟΥ ΒΡΙΣΚΟΜΑΣΤΕ;
CLIP ΜΙΤΡΟΕΙ ΟΥΣ: ΠΟΥ ΒΡΙΣΚΟΜΑΣΤΕ; Επιµορφωτικά Σεµινάρια Ειδικευοµένων Καρδιολογίας 7 Απριλίου 2012 M Chrissoheris MD FACC THV Department HYGEIA Hospital Degenerative MR (DMR) Usually refers to an anatomic
More informationRole of CMR in heart failure and cardiomyopathy
Role of CMR in heart failure and cardiomyopathy Hajime Sakuma Department of Radiology, Mie University Late gadolinium enhancement (LGE) LGE MRI can demonstrate site of necrosis, fibrosis or deposition
More informationCardiac Magnetic Resonance in pregnant women
Cardiac Magnetic Resonance in pregnant women Chen SSM, Leeton L, Dennis AT Royal Women s Hospital and The University of Melbourne, Parkville, Australia alicia.dennis@thewomens.org.au Quantification of
More informationHypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy From Genetics to ECHO Alexandra A Frogoudaki Second Cardiology Department ATTIKON University Hospital Athens University Athens, Greece EUROECHO 2010, Copenhagen, 11/12/2010
More informationMyocardial Strain Imaging in Cardiac Diseases and Cardiomyopathies.
Myocardial Strain Imaging in Cardiac Diseases and Cardiomyopathies. Session: Cardiomyopathy Tarun Pandey MD, FRCR. Associate Professor University of Arkansas for Medical Sciences Disclosures No relevant
More informationMitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France
Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines Christophe Tribouilloy Amiens, France I have no financial relationships to disclose related
More informationVelocity Vector Imaging as a new approach for cardiac magnetic resonance: Comparison with echocardiography
Velocity Vector Imaging as a new approach for cardiac magnetic resonance: Comparison with echocardiography Toshinari Onishi 1, Samir K. Saha 2, Daniel Ludwig 1, Erik B. Schelbert 1, David Schwartzman 1,
More informationCardiac hypertrophy and how it may break an athlete s heart e the Cypriot case
Eur J Echocardiography (2005) 6, 301e307 Cardiac hypertrophy and how it may break an athlete s heart e the Cypriot case C.E. Chee a,1, C.P. Anastassiades a,1, A.G. Antonopoulos b, A.A. Petsas b, L.C. Anastassiades
More informationRepair or Replacement
Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division
More informationThe Mitral Revolution: Transcatheter Repair (and Replacement?) Going Mainstream
The Mitral Revolution: Transcatheter Repair (and Replacement?) Going Mainstream Matthew J. Price MD Director, Cardiac Catheterization Laboratory Scripps Clinic La Jolla, CA, USA price.matthew@scrippshealth.org
More informationGeometric Assessment of Asymmetric Septal Hypertrophic Cardiomyopathy by CMR
JACC: CARDIOVASCULAR IMAGING VOL. 5, NO. 7, 212 212 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/$36. PUBLISHED BY ELSEVIER INC. http://dx.doi.org/1.116/j.jcmg.212.3.11 Geometric Assessment
More informationRegurgitant Lesions. Bicol Hospital, Legazpi City, Philippines July Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA
Regurgitant Lesions Bicol Hospital, Legazpi City, Philippines July 2016 Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA Aortic Insufficiency Valve anatomy and function LVOT and
More information